Blood, tissues, cells and organs - Key documents

2023 RAB and RATC annual summary of activity

Summary of the 2022 (2021 data) annual reporting of serious adverse reactions and events for blood and blood components

Blood - Common approach for definition of reportable Serious Adverse Events and Reactions (SARE)

Summary of the 2021 (2020 data) annual reporting of serious adverse reactions and events for tissues and cells

2022 RAB and RATC annual summary of activity

2021 RAB and RATC annual summary of activity

Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components

2020 RAB and RATC annual summary of activity

Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components

2019 RAB and RATC annual summary of activity

Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components

2018 RAB and RATC annual summary of activity

Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components

2017 RAB and RATC annual summary of activity

Summary of the 2016 annual reporting of serious adverse reactions and events for blood and blood components

2016 RAB annual summary of activity

Summary of the 2015 annual reporting of serious adverse reactions and events for blood and blood components

2015 RAB annual summary of activity

COM(2016) 224 final